User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapy.

  1. Lancet, 344, 1383 (1994)
  2. Becker Matthijs L, Visser Loes E, van Schaik Ron HN, Hofman Albert, Uitterlinden André G, Stricker Bruno HCh, Common genetic variation in theABCB1gene is associated with the cholesterol-lowering effect of simvastatin in males, 10.2217/pgs.09.105
  3. Rodrigues Alice C, Efflux and uptake transporters as determinants of statin response, 10.1517/17425251003713519
  4. SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study, 10.1056/nejmoa0801936
  5. Cascorbi Ingolf, Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs, 10.1016/j.pharmthera.2006.04.009
  6. Giacomini Kathleen M., Huang Shiew-Mei, Tweedie Donald J., Benet Leslie Z., Brouwer Kim L.R., Chu Xiaoyan, Dahlin Amber, Evers Raymond, Fischer Volker, Hillgren Kathleen M., Hoffmaster Keith A., Ishikawa Toshihisa, Keppler Dietrich, Kim Richard B., Lee Caroline A., Niemi Mikko, Polli Joseph W., Sugiyama Yuicchi, Swaan Peter W., Ware Joseph A., Wright Stephen H., Wah Yee Sook, Zamek-Gliszczynski Maciej J., Zhang Lei, Membrane transporters in drug development, 10.1038/nrd3028
  7. Kivisto K. T., DISPOSITION OF ORAL AND INTRAVENOUS PRAVASTATIN IN MRP2-DEFICIENT TR- RATS, 10.1124/dmd.105.006262
  8. Li J., Volpe D. A., Wang Y., Zhang W., Bode C., Owen A., Hidalgo I. J., Use of Transporter Knockdown Caco-2 Cells to Investigate the In Vitro Efflux of Statin Drugs, 10.1124/dmd.111.038075
  9. Laechelt S, Turrini E, Ruehmkorf A, Siegmund W, Cascorbi I, Haenisch S, Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function, 10.1038/tpj.2010.20
  10. Becker Matthijs L., Visser Loes E., van Schaik Ron H. N., Hofman Albert, Uitterlinden André G., Ch. Stricker Bruno H., Influence of genetic variation inCYP3A4andABCB1on dose decrease or switching during simvastatin and atorvastatin therapy, 10.1002/pds.1866
  11. Hofman Albert, Breteler Monique M. B., van Duijn Cornelia M., Janssen Harry L. A., Krestin Gabriel P., Kuipers Ernst J., Stricker Bruno H. Ch., Tiemeier Henning, Uitterlinden André G., Vingerling Johannes R., Witteman Jacqueline C. M., The Rotterdam Study: 2010 objectives and design update, 10.1007/s10654-009-9386-z
  12. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG, Andrew T, Falchi M, Gwilliam R, Ahmadi KR, Valdes AM, Arp P, Whittaker P, Verlaan DJ, Jhamai M, Kumanduri V, Moorhouse M, van Meurs JB, Hofman A, Pols HAP, Hart D, Zhai G, Kato BS, Mullin BH, Zhang F, Deloukas P, Uitterlinden AG, Spector TD, Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study, 10.1016/s0140-6736(08)60599-1
  13. , , Gibbs Richard A., Belmont John W., Hardenbol Paul, Willis Thomas D., Yu Fuli, Yang Huanming, Ch'ang Lan-Yang, Huang Wei, Liu Bin, Shen Yan, Tam Paul Kwong-Hang, Tsui Lap-Chee, Waye Mary Miu Yee, Wong Jeffrey Tze-Fei, Zeng Changqing, Zhang Qingrun, Chee Mark S., Galver Luana M., Kruglyak Semyon, Murray Sarah S., Oliphant Arnold R., Montpetit Alexandre, Hudson Thomas J., Chagnon Fanny, Ferretti Vincent, Leboeuf Martin, Phillips Michael S., Verner Andrei, Kwok Pui-Yan, Duan Shenghui, Lind Denise L., Miller Raymond D., Rice John P., Saccone Nancy L., Taillon-Miller Patricia, Xiao Ming, Nakamura Yusuke, Sekine Akihiro, Sorimachi Koki, Tanaka Toshihiro, Tanaka Yoichi, Tsunoda Tatsuhiko, Yoshino Eiji, Bentley David R., Deloukas Panos, Hunt Sarah, Powell Don, Altshuler David, Gabriel Stacey B., Zhang Houcan, Zeng Changqing, Matsuda Ichiro, Fukushima Yoshimitsu, Macer Darryl R., Suda Eiko, Rotimi Charles N., Adebamowo Clement A., Aniagwu Toyin, Marshall Patricia A., Matthew Olayemi, Nkwodimmah Chibuzor, Royal Charmaine D. M., Leppert Mark F., Dixon Missy, Stein Lincoln D., Cunningham Fiona, Kanani Ardavan, Thorisson Gudmundur A., Chakravarti Aravinda, Chen Peter E., Cutler David J., Kashuk Carl S., Donnelly Peter, Marchini Jonathan, McVean Gilean A. T., Myers Simon R., Cardon Lon R., Abecasis Gonçalo R., Morris Andrew, Weir Bruce S., Mullikin James C., Sherry Stephen T., Feolo Michael, Altshuler David, Daly Mark J., Schaffner Stephen F., Qiu Renzong, Kent Alastair, Dunston Georgia M., Kato Kazuto, Niikawa Norio, Knoppers Bartha M., Foster Morris W., Clayton Ellen Wright, Wang Vivian Ota, Watkin Jessica, Gibbs Richard A., Belmont John W., Sodergren Erica, Weinstock George M., Wilson Richard K., Fulton Lucinda L., Rogers Jane, Birren Bruce W., Han Hua, Wang Hongguang, Godbout Martin, Wallenburg John C., L'Archevêque Paul, Bellemare Guy, Todani Kazuo, Fujita Takashi, Tanaka Satoshi, Holden Arthur L., Lai Eric H., Collins Francis S., Brooks Lisa D., McEwen Jean E., Guyer Mark S., Jordan Elke, Peterson Jane L., Spiegel Jack, Sung Lawrence M., Zacharia Lynn F., Kennedy Karen, Dunn Michael G., Seabrook Richard, Shillito Mark, Skene Barbara, Stewart John G., Valle (chair) David L., Clayton (co-chair) Ellen Wright, Jorde (co-chair) Lynn B., Belmont John W., Chakravarti Aravinda, Cho Mildred K., Duster Troy, Foster Morris W., Jasperse Marla, Knoppers Bartha M., Kwok Pui-Yan, Licinio Julio, Long Jeffrey C., Marshall Patricia A., Ossorio Pilar N., Wang Vivian Ota, Rotimi Charles N., Royal Charmaine D. M., Spallone Patricia, Terry Sharon F., Lander (chair) Eric S., Lai (co-chair) Eric H., Nickerson (co-chair) Deborah A., Abecasis Gonçalo R., Altshuler David, Bentley David R., Boehnke Michael, Cardon Lon R., Daly Mark J., Deloukas Panos, Douglas Julie A., Gabriel Stacey B., Hudson Richard R., Hudson Thomas J., Kruglyak Leonid, Kwok Pui-Yan, Nakamura Yusuke, Nussbaum Robert L., Royal Charmaine D. M., Schaffner Stephen F., Sherry Stephen T., Stein Lincoln D., Tanaka Toshihiro, , The International HapMap Project, 10.1038/nature02168
  14. Fang Yue, van Meurs Joyce B.J., d'Alesio Arnold, Jhamai Mila, Zhao Hongyan, Rivadeneira Fernando, Hofman Albert, van Leeuwen Johannes P.T., Jehan Frédéric, Pols Huibert A.P., Uitterlinden André G., Promoter and 3′-Untranslated-Region Haplotypes in the Vitamin D Receptor Gene Predispose to Osteoporotic Fracture: The Rotterdam Study, 10.1086/497438
  15. Stephens Matthew, Donnelly Peter, A Comparison of Bayesian Methods for Haplotype Reconstruction from Population Genotype Data, 10.1086/379378
  16. Stephens Matthew, Smith Nicholas J., Donnelly Peter, A New Statistical Method for Haplotype Reconstruction from Population Data, 10.1086/319501
  17. Cummins C, Sex-related differences in the clearance of cytochrome P450 3A4 substrates may be caused by P-glycoprotein, 10.1067/mcp.2002.128388
  18. Wacher Vincent J., Silverman Jeffrey A., Zhang Yuanchao, Benet Leslie Z., Role of P-Glycoprotein and Cytochrome P450 3A in Limiting Oral Absorption of Peptides and Peptidomimetics†, 10.1021/js980082d
  19. Chen C., Lin J., Smolarek T., Tremaine L., P-glycoprotein Has Differential Effects on the Disposition of Statin Acid and Lactone Forms in mdr1a/b Knockout and Wild-Type Mice, 10.1124/dmd.107.015677
  20. Chen C., DIFFERENTIAL INTERACTION OF 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE INHIBITORS WITH ABCB1, ABCC2, AND OATP1B1, 10.1124/dmd.104.002477
  21. Keskitalo JE, Kurkinen KJ, Neuvonen PJ, Niemi M, ABCB1 Haplotypes Differentially Affect the Pharmacokinetics of the Acid and Lactone Forms of Simvastatin and Atorvastatin, 10.1038/clpt.2008.25
  22. FIEGENBAUM M, DASILVEIRA F, VANDERSAND C, VANDERSAND L, FERREIRA M, PIRES R, HUTZ M, The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment, 10.1016/j.clpt.2005.08.003
  23. Donnelly L A, Doney A S F, Tavendale R, Lang C C, Pearson E R, Colhoun H M, McCarthy M I, Hattersley A T, Morris A D, Palmer C N A, Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study, 10.1038/clpt.2010.255
Bibliographic reference Becker, M L ; Elens, Laure ; Visser, L E ; Hofman, A ; Uitterlinden, A G ; et. al. Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapy.. In: The Pharmacogenomics Journal, Vol. 13, no.3, p. 251-256 (2011)
Permanent URL http://hdl.handle.net/2078.1/161651